Vertiv (VRT) director exercises 38,647 options and sells shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vertiv Holdings Co director Jan van Dokkum reported multiple transactions in Vertiv (VRT) shares on February 26, 2026. He exercised 38,647 stock options at $20.56 per share, receiving the same number of Class A common shares.
On the same day, he sold 22,989 shares at a weighted average price of $254.49 and 15,658 shares at a weighted average price of $255.42 in open-market transactions. After these trades, he directly held 25,000 shares of Class A common stock, and several additional stock option grants with scheduled vesting dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 38,647 shares ($9,849,837)
Net Sell
8 txns
Insider
DOKKUM JAN VAN
Role
Director
Sold
38,647 shs ($9.85M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 38,647 | $20.56 | $795K |
| Exercise | Class A Common Stock | 38,647 | $20.56 | $795K |
| Sale | Class A Common Stock | 22,989 | $254.49 | $5.85M |
| Sale | Class A Common Stock | 15,658 | $255.42 | $4.00M |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Holdings After Transaction:
Stock Option — 0 shares (Direct);
Class A Common Stock — 63,647 shares (Direct)
Footnotes (1)
- Reported shares shown are held by Mr. Joseph van Dokkum and Mrs. Lynn van Dokkum, as tenants in common. The trade was executed in a series of transactions with a price range of $254.00 to $254.99, inclusive, with a weighted average price of $254.49. The reporting person undertakes to provide to Vertiv Holdings Co, any security holder of Vertiv Holdings Co, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3. The trade was executed in a series of transactions with a price range of $255.04 to $255.84, inclusive, with a weighted average price of $255.42. Consists of 38,647 stock options granted on February 4, 2021, which vested as to 9,662 on each of February 4, 2022, February 4, 2023 and February 4, 2024, and as to 9,661 on February 4, 2025. Consists of 38,647 stock options granted on March 3, 2022, which vested as to 9,661 on March 3, 2023 and as to 9,662 on each of March 3, 2024 and March 3, 2025, and which will vest as to 9,662 on March 3, 2026. Consists of 30,000 stock options granted on March 7, 2023, which vested as to 7,500 on each of March 15, 2024 and March 15, 2025, and which will vest as to 7,500 on each of March 15, 2026 and March 15, 2027. Consists of 15,000 stock options granted on March 7, 2024, which vested as to 3,750 on March 15, 2025, and which will vest as to 3,750 on each of March 15, 2026, March 15, 2027 and March 15, 2028. Consists of 15,000 stock options granted on March 7, 2025, which will vest as to 3,750 on each of March 15, 2026, March 15, 2027, March 15, 2028 and March 15, 2029.
FAQ
What insider transactions did Vertiv (VRT) director Jan van Dokkum report?
Jan van Dokkum reported exercising 38,647 stock options at $20.56 per share and receiving an equal number of Vertiv Class A shares. He then sold 22,989 shares at $254.49 and 15,658 shares at $255.42 in open-market transactions on February 26, 2026.
What stock options did Jan van Dokkum exercise in the Vertiv (VRT) Form 4?
He exercised 38,647 stock options at $20.56 per share, converting them into an equal number of Vertiv Class A common shares. The options were originally granted in 2021 and had vested in four annual installments through February 4, 2025, as described in a footnote.
What future vesting schedule do Vertiv (VRT) options held by Jan van Dokkum have?
Footnotes explain several option grants with future vesting dates, including options granted in 2022, 2023, 2024, and 2025. These vest in equal annual installments on March 3 or March 15 of each year from 2026 through 2029, subject to their respective grant terms.